Skip to content
10-Q

Quarterly Report

CV Sciences, Inc. CVSI

0001193125-26-226702

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 11, 2026 203.98M sh
Shares Diluted Q1 2026 · Mar 31, 2026 186.92M sh
Shares Diluted Q1 2026 · Mar 31, 2025 184.26M sh
Capex Q1 2026 · Mar 31, 2026 $3K
Capex Q1 2026 · Mar 31, 2025 $40K
Operating Cash Flow Q1 2026 · Mar 31, 2026 $101K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$81K
Long Term Debt Q1 2026 · Mar 31, 2026 $0
Long Term Debt Q1 2026 · Dec 31, 2025 $387K
Short Term Debt Q1 2026 · Mar 31, 2026 $72K
Short Term Debt Q1 2026 · Dec 31, 2025 $1.26M
Stockholders Equity Q1 2026 · Mar 31, 2026 $1.5M
Stockholders Equity Q1 2026 · Dec 31, 2025 $1.47M
Stockholders Equity Q1 2026 · Mar 31, 2025 $1.89M
Stockholders Equity Q1 2026 · Dec 31, 2024 $1.8M
Current Liabilities Q1 2026 · Mar 31, 2026 $5.18M
Current Liabilities Q1 2026 · Dec 31, 2025 $5M
Total Liabilities Q1 2026 · Mar 31, 2026 $5.22M
Total Liabilities Q1 2026 · Dec 31, 2025 $5.49M
Current Assets Q1 2026 · Mar 31, 2026 $5M
Current Assets Q1 2026 · Dec 31, 2025 $5.13M
Total Assets Q1 2026 · Mar 31, 2026 $6.72M
Total Assets Q1 2026 · Dec 31, 2025 $6.96M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.00
Eps Diluted Q1 2026 · Mar 31, 2025 $0.00
Eps Basic Q1 2026 · Mar 31, 2026 $0.00
Eps Basic Q1 2026 · Mar 31, 2025 $0.00
Sga Expense Q1 2026 · Mar 31, 2026 $1.86M
Sga Expense Q1 2026 · Mar 31, 2025 $2.14M
Rd Expense Q1 2026 · Mar 31, 2026 $18K
Rd Expense Q1 2026 · Mar 31, 2025 $30K
Net Income Q1 2026 · Mar 31, 2026 −$643K
Net Income Q1 2026 · Mar 31, 2025 −$109K
Operating Income Q1 2026 · Mar 31, 2026 −$318K
Operating Income Q1 2026 · Mar 31, 2025 $11K
Gross Profit Q1 2026 · Mar 31, 2026 $1.56M
Gross Profit Q1 2026 · Mar 31, 2025 $1.66M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $1.63M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $1.95M
Revenue Q1 2026 · Mar 31, 2026 $3.2M
Revenue Q1 2026 · Mar 31, 2025 $3.61M